EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Anti-HCV Seropositivity with Blood Transfusion and the Hidden Burden of Warm Blood Transfusion in a Resource-Limited Setting: An Analytical Cross-Sectional Study from Mbujimayi, Democratic Republic of Congo

Georges Ntambwe, Désiré Baloji, Venance Muepu, William Kidinda, Benoit Kazadi, Jean Robert Tshibinkufua, Christian Tague, Bertin Mukuna Nyembo, Michel Kabamba Nzaji, André Mutombo Kabamba, Philippe Mulenga-Cilundika, Criss Koba Mjumbe und 2 weitere

F1000Research · 10.11.2026 · 15 · 1086

DOI: 10.12688/f1000research.183575.3 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift F1000Research, online erschienen am 10.11.2026. Verfasst von Georges Ntambwe und 13 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blood transfusion remains essential in clinical care, but unsafe transfusion pathways continue to expose recipients to transfusion-transmitted infections (TTIs). In the Democratic Republic of the Congo (DRC), substantial proportion of blood units are released before the mandatory infectious-marker screening has been completed. This study aimed to compare anti-HCV seroprevalence between recipients of warm and of cold transfusion in Mbujimayi.

Methods

We conducted a prospective analytical cross-sectional study in four high-transfusion-volume hospitals of Mbujimayi from April 8 to 24, 2024. A total of 223 previously transfused individuals (at least 2-months after transfusion) were enrolled and classified as exposed (warm transfusion, i.e., a unit released before complete validation of the mandatory screening panel) or unexposed (cold transfusion, i.e., a fully validated unit). Anti-HCV antibodies were detected with an HCV Scan rapid immunochromatographic assay on serum. Crude (cOR) and adjusted (aOR) odds ratios with 95% confidence intervals were estimated by bivariate analysis and multivariable logistic regression in IBM SPSS Statistics version 27, p < 0.05 was considered statistically significant.

Results

Anti-HCV seroprevalence was 4.9% (11/223) overall, 9.2% (10/109) in the warm-transfusion group and 0.9% (1/114) in the cold-transfusion group (cOR = 11.41; 95% CI 1.44–90.75; p = 0.004). After adjustment, for the number of transfusions received and a history of jaundice, this association was attenuated and no longer statistically significant (aOR = 4.09; 95% CI 0.80–40.59; p = 0.095). In the model with anti-HCV seropositivity as the dependent variable, receiving more than one transfusion (aOR = 4.99; 95% CI 1.28–23.21; p = 0.021). In the separate model with warm transfusion as the dependent variable, receiving more than one transfusion (aOR = 10.03; 95% CI 3.85–26.16; p < 0.001) and absence of waged employment (aOR = 4.66; 95% CI 1.18–18.41; p = 0.028) were independently associated with exposure to warm transfusion; these two estimates concern the transfusion pathway, not the risk of HCV infection. Pathway, not the risk of HCV.

Conclusion

Warm-transfusion was associated with a markedly higher anti-HCV seroprevalence; however, the small number of outcome events limits the precision of the estimates. In the absence of pre-transfusion serological serostatus and of a confirmatory RNA test, the findings reflect seropositivity rather than transfusion-attributable infection. Strengthening voluntary blood donation, ensuring uninterrupted screening and enforcing the systematic use of pre-tested blood units remain the essential levers of improvement.

Zitieren

APA

Ntambwe, G., Baloji, D., Muepu, V., Kidinda, W., Kazadi, B., Tshibinkufua, J. R., Tague, C., Nyembo, B. M., Nzaji, M. K., Kabamba, A. M., Mulenga-Cilundika, P., Mjumbe, C. K., Mpanya, A., & Lutumba, P. (2026). Anti-HCV Seropositivity with Blood Transfusion and the Hidden Burden of Warm Blood Transfusion in a Resource-Limited Setting: An Analytical Cross-Sectional Study from Mbujimayi, Democratic Republic of Congo. F1000Research, 15, 1086. https://doi.org/10.12688/f1000research.183575.3

Vancouver

Ntambwe G, Baloji D, Muepu V, Kidinda W, Kazadi B, Tshibinkufua JR, et al. Anti-HCV Seropositivity with Blood Transfusion and the Hidden Burden of Warm Blood Transfusion in a Resource-Limited Setting: An Analytical Cross-Sectional Study from Mbujimayi, Democratic Republic of Congo. F1000Research. 2026;15:1086. doi:10.12688/f1000research.183575.3

BibTeX
@article{Ntambwe2026,
  author = {Ntambwe, Georges and Baloji, Désiré and Muepu, Venance and Kidinda, William and Kazadi, Benoit and Tshibinkufua, Jean Robert and Tague, Christian and Nyembo, Bertin Mukuna and Nzaji, Michel Kabamba and Kabamba, André Mutombo and Mulenga-Cilundika, Philippe and Mjumbe, Criss Koba and Mpanya, Alain and Lutumba, Pascal},
  title = {Anti-HCV Seropositivity with Blood Transfusion and the Hidden Burden of Warm Blood Transfusion in a Resource-Limited Setting: An Analytical Cross-Sectional Study from Mbujimayi, Democratic Republic of Congo},
  journal = {F1000Research},
  year = {2026},
  volume = {15},
  pages = {1086},
  doi = {10.12688/f1000research.183575.3}
}
Kostenlos starten →